BiotechTube
Home/Navamedic/Nils Ole Krekling
NO

Nils Ole Krekling

Chief Financial Officer

Navamedic

Therapeutic Areas

Parkinson's DiseaseInherited Metabolic Disorders (e.g., PKU)Medical Nutrition

Navamedic Pipeline

DrugIndicationPhase
Enhanced Parkinson Care InnovationParkinson's DiseaseCommercial
In Good Company (I Gott Sällskap)Phenylketonuria (PKU) & related metabolic disordersCommercial Support Program